(AOF) – NFL Biosciences announces that it has been selected by the SRNT (Society for Research on Nicotine & Tobacco) to present the results of the Precesto study at the international congress of this world-leading scientific society in the fight against Smoking , which will be held in Edinburgh, Scotland from March 20-23. Conducted in 2023 on 34 smokers who did not wish to quit smoking, the study demonstrated the effectiveness of the drug candidate NFL-101 in reducing the satisfaction of smoking compared to a placebo.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
